These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Essa Pharma (EPIX), 7,060% surge in interest Chromadex (CDXC),
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Essa Pharma (EPIX), 7,060% surge in interest Chromadex (CDXC),
H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on CDXC stock, giving a Buy rating on October 22. Ram Selvaraju has given his Buy rating due to a
H.C. Wainwright raised the firm’s price target on ChromaDex (CDXC) to $8 from $6 and keeps a Buy rating on the shares post the Q3 report. The company reported slight